Spartan Capital Securities served as sole placement agent for Virpax Pharmaceuticals in $6 million offering.

From GlobeNewswire: 2025-01-30 15:59:00

Spartan Capital Securities, LLC served as the sole placement agent for Virpax Pharmaceuticals, Inc. in a successful $6 million follow-on offering. The funds will support clinical trial development of Probudur, marketing efforts, and general corporate purposes. Legal counsel was provided by Sichenzia Ross Ference Carmel LLP for Virpax and Lucosky Brookman LLP for Spartan Capital. Virpax is focused on developing non-opioid, non-addictive treatments for pain and central nervous system disorders. Spartan Capital is known for its expertise in capital raising and strategic advisory services. For more information, visit www.spartancapital.com.



Read more at GlobeNewswire: Spartan Capital Securities Serves as Sole Placement Agent